Impact of prior knowledge of mutation status on tumor stage in BRCA1/2 mutation carriers with newly diagnosed breast cancer.

被引：2
|
作者：
Yam, Clinton
Stopfer, Jill
Brandt, Amanda
Powers, Jacquelyn
Long, Jessica M.
Maxwell, Kara Noelle
Bradbury, Angela R.
Nathanson, Katherine L.
Domchek, Susan M.
机构：
[1] Univ Penn, Abramson Canc Ctr, Basser Res Ctr BRCA, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Philadelphia, PA 19104 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.1562
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1562
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Medical Management of newly diagnosed breast cancer in a BRCA1/2 mutation carrier
    Desai, Neelam V.
    Tung, Nadine M.
    BREAST JOURNAL, 2020, 26 (08): : 1506 - 1512
  • [2] Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers
    Krammer, Julia
    Pinker-Domenig, Katja
    Robson, Mark E.
    Gonen, Mithat
    Bernard-Davila, Blanca
    Morris, Elizabeth A.
    Mangino, Debra A.
    Jochelson, Maxine S.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (03) : 565 - 571
  • [3] Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers
    Julia Krammer
    Katja Pinker-Domenig
    Mark E. Robson
    Mithat Gönen
    Blanca Bernard-Davila
    Elizabeth A. Morris
    Debra A. Mangino
    Maxine S. Jochelson
    Breast Cancer Research and Treatment, 2017, 163 : 565 - 571
  • [4] Management of breast cancer in BRCA1/2 mutation carriers
    Eeles, RA
    Camplejohn, R
    Peacock, J
    McMillan, T
    DISEASE MARKERS, 1999, 15 (1-3) : 204 - 204
  • [5] AURKA and breast cancer in BRCA1/2 mutation carriers
    Bodvarsdottir, Sigridur K.
    Vidarsdottir, Linda
    Eyfjord, Jorunn E.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (11) : 2517 - 2517
  • [6] Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients
    Schwartz, MD
    Lerman, C
    Brogan, B
    Peshkin, BN
    Isaacs, C
    DeMarco, T
    Halbert, CH
    Pennanen, M
    Finch, C
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (04) : 1003 - 1007
  • [7] Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Metcalfe, K
    Lynch, HT
    Chadirian, P
    Tung, N
    Olivotto, V
    Warner, E
    Olopade, OI
    Eisen, A
    Weber, B
    McLennan, J
    Sun, P
    Foulkes, WD
    Narod, SA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) : 2328 - 2335
  • [8] Prognosis of BRCA1 and BRCA2 mutation carriers with breast cancer
    Rennert, G
    Bisland-Becktell, S
    Almog, R
    Zhang, S
    Rennert, HS
    Narod, S
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (02) : 221 - 221
  • [9] Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
    Warner, Ellen
    CANCERS, 2018, 10 (12)
  • [10] Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence
    Shah, P.
    Rosen, M.
    Stopfer, J.
    Siegfried, J.
    Kaltman, R.
    Mason, B.
    Armstrong, K.
    Nathanson, K. L.
    Schnall, M.
    Domchek, S. M.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 118 (03) : 539 - 546
12345